Literature DB >> 16459016

PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence.

Paul Perrin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16459016     DOI: 10.1016/j.eururo.2005.12.028

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  6 in total

Review 1.  PSA Velocity in Risk Stratification of Prostate Cancer.

Authors:  Marc A Bjurlin; Stacy Loeb
Journal:  Rev Urol       Date:  2013

2.  Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.

Authors:  Steven J Jacobsen; Debra J Jacobson; Michaela E McGree; Jennifer L St Sauver; George G Klee; Cynthia J Girman; Michael M Lieber
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

3.  Prostate cancer: is PSA velocity useful?

Authors:  Stacy Loeb
Journal:  Nat Rev Urol       Date:  2009-06       Impact factor: 14.432

4.  PSA doubling time versus PSA velocity to predict high-risk prostate cancer: data from the Baltimore Longitudinal Study of Aging.

Authors:  Stacy Loeb; Anna Kettermann; Luigi Ferrucci; Patricia Landis; E Jeffrey Metter; H Ballentine Carter
Journal:  Eur Urol       Date:  2008-07-02       Impact factor: 20.096

Review 5.  Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.

Authors:  Andrew J Vickers; Caroline Savage; M Frank O'Brien; Hans Lilja
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

6.  Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.

Authors:  Aruna V Sarma; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; George G Klee; Michael M Lieber; Cynthia J Girman; John M Hollingsworth; Steven J Jacobsen
Journal:  Urology       Date:  2013-10-16       Impact factor: 2.649

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.